emo Phase II/III STORM-C-1 trial results from EASL 2018

4 years 3 months ago #26267

Brief article outlining the Phase II/III STORM-C-1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris


The following user(s) said Thank You: coral, hanknassi, Mar

Please Log in or Create an account to join the conversation.

Time to create page: 0.032 seconds

Copyright © 2015-2020 FixHepC

Back to Top